Market Dynamics:
The growing prevalence of neurological disorders has been a key driver for the neurological biomarkers market. According to World Health Organization estimates, over 1 billion people globally suffer from neurological disorders with Alzheimer's disease and other dementias affecting over 55 million people worldwide. Such high disease prevalence has created significant need for...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian